Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$13.97 -0.05 (-0.36%)
As of: Sep 4, 2026 · 3:21 PM EDT

Enanta Pharmaceuticals (ENTA) Tax Rate (QoQ) (2014 - 2026)

Analysis

Enanta Pharmaceuticals (ENTA) Tax Rate (QoQ) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Enanta Pharmaceuticals 404.93 Mn 215.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.00
Mar 31, 2026 15.00
Dec 31, 2025 -63.00
Sep 30, 2025 59.00
Jun 30, 2025 -561.00
Mar 31, 2025 362.00
Dec 31, 2024 -7.00
Sep 30, 2024 19.00
Jun 30, 2024 56.00
Mar 31, 2024 -68.00
Dec 31, 2023 -295.00
Sep 30, 2023 1,689.00
Jun 30, 2023 -1,200.00
Mar 31, 2023 -23.00
Dec 31, 2022 11.00
Sep 30, 2022 -138.00
Dec 31, 2021 -2,663.00
Sep 30, 2021 -134.00
Jun 30, 2021 5,248.00
Mar 31, 2021 -5,273.00